1. MicroRNAs in regulation of triple-negative breast cancer progression

   • Dominika Piasecka
   • Marcin Braun
   • Hanna Romanska

   Review – Cancer Research Open access 19 June 2018 Pages: 1401 - 1411

   

2. Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial–mesenchymal transition phenotype

   • Jing Xu
   • Xiaoting Zhao
   • Shucai Zhang

   Original Article – Cancer Research 24 May 2018 Pages: 1413 - 1422

   

3. Relationship between TNF-α −1031T/C gene polymorphism, plasma level of TNF-α, and risk of cachexia in head and neck cancer patients

   • Tomasz Powrózek
   • Radosław Mlak
   • Teresa Małecka-Massalska

   Original Article – Cancer Research Open access 25 May 2018 Pages: 1423 - 1434

   

4. Machine learning identifies a core gene set predictive of acquired resistance to EGFR tyrosine kinase inhibitor

   • Young Rae Kim
   • Sung Young Kim

   Original Article – Cancer Research 25 May 2018 Pages: 1435 - 1444

   

5. TIS21^/BTG2 inhibits breast cancer growth and progression by differential regulation of mTORc1 and mTORc2–AKT1–NFAT1–PHLPP2 signaling axis

   • Santhoshkumar Sundaramoorthy
   • Preethi Devanand
   • In Kyoung Lim

   Original Article – Cancer Research 28 May 2018 Pages: 1445 - 1462

   

6. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells

   • Yi-Fan Li
   • Hou-Ting Zhang
   • Lin Xin

   Original Article – Cancer Research 01 June 2018 Pages: 1463 - 1473

   

7. Effects of sequentially applied single and combined temozolomide, hydroxychloroquine and AT101 treatment in a long-term stimulation glioblastoma in vitro model

   • Vivian Adamski
   • Christina Schmitt
   • Janka Held-Feindt

   Original Article – Cancer Research 01 June 2018 Pages: 1475 - 1485

   

8. Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines

   • Jin Sun Kim
   • Gwang Hyeon Choi
   • Han Chu Lee

   Original Article – Cancer Research 01 June 2018 Pages: 1487 - 1501

   

9. Emerging strategies in BRCA-positive pancreatic cancer

   • Adam Kowalewski
   • Łukasz Szylberg
   • Dariusz Grzanka

   Review – Clinical Oncology Open access 18 May 2018 Pages: 1503 - 1507

   

10. Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma

    • Kai Wang
    • Xiao Qu
    • Jiajun Du

    Original Article – Clinical Oncology 04 May 2018 Pages: 1509 - 1521

    

11. Vaginal brachytherapy for endometrial cancer

    • Peter Hass
    • Selvi Seinsch
    • Atanas Ignatov

    Original Article – Clinical Oncology 05 May 2018 Pages: 1523 - 1530

    

12. Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional study

    • Florian Nolte
    • Holger Nückel
    • Wolf-Karsten Hofmann

    Original Article – Clinical Oncology 14 May 2018 Pages: 1531 - 1538

    

13. Outcomes of Takotsubo cardiomyopathy in hospitalized cancer patients

    • Parijat Saurav Joy
    • Achuta Kumar Guddati
    • Iuliana Shapira

    Original Article – Clinical Oncology 14 May 2018 Pages: 1539 - 1545

    

14. Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer

    • Koji Takada
    • Shinichiro Kashiwagi
    • Masaichi Ohira

    Original Article – Clinical Oncology Open access 19 May 2018 Pages: 1547 - 1559

    

15. Patterns of platinum drug use in an acute care setting: a retrospective study

    • Evangeline Armstrong-Gordon
    • Danijela Gnjidic
    • Nial J. Wheate

    Original Article – Clinical Oncology 22 May 2018 Pages: 1561 - 1568

16. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients

    • Neval E. Wareham
    • Amanda Mocroft
    • MATCH in PERSIMUNE study group

    Original Article – Clinical Oncology 26 May 2018 Pages: 1569 - 1580

    

17. Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial

    • Christina Schaub
    • Sied Kebir
    • Martin Glas

    Original Article – Clinical Oncology 28 May 2018 Pages: 1581 - 1589

    

18. End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer

    • Yingming Zhu
    • Ke Tang
    • Jinming Yu

    Original Article – Clinical Oncology 29 May 2018 Pages: 1591 - 1599

    

19. Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations

    • Yusuke Okuma
    • Jumpei Kashima
    • Sadamu Homma

    Original Article – Clinical Oncology 01 June 2018 Pages: 1601 - 1611

    

20. Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients

    • Tiina Moilanen
    • Anna Jokimäki
    • Jussi P. Koivunen

    Original Article – Clinical Oncology 05 June 2018 Pages: 1613 - 1621